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Structure 1996, Vol 4 No 1:000–000
n A helical arch allowing single-stranded DNA to thread
through T5 5¢-exonuclease. TA Ceska, JR Sayers, G Stier
and D Suck (1996). Nature 382, 90–93.
As well as their exonucleolytic action, removing nucleotides
from the 5′-end of nucleic acid molecules such as Okazaki
fragments, many 5′-3′-exonucleases have been shown to
possess endonucleolytic activities. T5 5′-3′-exonuclease shares
many similarities with the amino terminal of eubacterial DNA
polymerases. The authors report the 2.5 Å crystal structure of
the phage T5′-exonuclease, which reveals a helical arch for
binding DNA. They propose a model consistent with a
threading mechanism in which single-stranded DNA could
slide through the arch, which is formed by two helices, one
containing positively charged, and the other hydrophobic,
residues. The active site is at the base of the arch, and contains
two metal-binding sites.
4 July 1996, Nature
n Structural basis of RNA folding and recognition in an
AMP–RNA aptamer complex. Feng Jiang, R Ajay Kumar,
Roger A Jones and Dinshaw J Patel (1996). Nature 382,
183–186.
In vitro selection techniques have been used to isolate RNA
sequences (‘aptamers’) containing a high-affinity binding site
for ATP. The authors present the NMR solution structure of a
40-mer RNA containing the ATP-binding motif complexed
with AMP. The aptamer adopts an L-shaped structure with
two nearly orthogonal stems, each capped proximally by a G·G
mismatch pair, binding the AMP ligand at their junction.
11 July 1996, Nature
n NMR structure of the mouse prion protein domain PrP
(121–231). Roland Riek, Simone Hornemann, Gerhard
Wider, Martin Billeter, Rudi Glockshuber and Kurt
Wüthrich (1996). Nature 382, 180–182.
The ‘protein only’ hypothesis states that a modified form of
normal prion protein triggers infectious neurodegenerative
diseases, such as bovine spongiform encephalopathy, or
Creutzfeldt-Jakob disease in humans. Prion proteins are
thought to exist in two different conformations: the ‘benign’
PrPC form, and the infectious ‘scrapie form’, PrPSc. The
solution structure of the autonomously folding PrP domain
(residues 121–231), described here, contains a two-stranded
antiparallel b sheet and three a helices. This domain contains
most of the point-mutation sites that have been linked, in
human PrP, to the occurrence of familial prion diseases. The
structure shows that these mutations occur within, or directly
adjacent to, regular secondary structures. The presence of a b
sheet is in contrast with model predictions of an all-helical
structure of PrPC.
11 July 1996, Nature
n Structure of Taq polymerase with DNA at the
polymerase active site. Soo Hyun Eom, Jimin Wang and
Thomas A Steitz (1996). Nature 382, 278–281.
The DNA polymerase from Thermus aquaticus (Taq
polymerase) contains domains responsible for DNA
polymerase and 5′ nuclease activities. The structures of the
polymerase domains of Taq polymerase and of the Klenow
fragment (KF) of DNA polymerase I (Pol I) are almost
identical, whereas the structure of the editing 3′−5′
exonuclease domain of Taq polymerase is dramatically altered,
resulting in the absence of this activity. The authors present
the co-crystal structure of Taq polymerase with a blunt-ended
duplex DNA bound to the polymerase active-site cleft; the
DNA neither bends nor goes through the large polymerase
cleft. The DNA is intermediate between the B and A forms.
Part of the DNA bound to the polymerase site shares a
common binding site with DNA bound to the exonuclease
site, but they are translated relative to each other by several
angstroms along their helix axes.
18 July 1996, Nature
n Crystal structure of the p27Kip1 cyclin-dependent-
kinase inhibitor bound to the cyclin A–Cdk2 complex.
Alicia A Russo, Philip D Jeffrey, Andrea K Patten, Joan
Massagué and Nikola P Pavletich (1996). Nature 382,
325–331.
Complexes of cyclins with cyclin-dependent kinases (CDKs)
play a central role in the control of the eukaryotic cell cycle.
The Kip/Cip family of inhibitors, which include p27Kip1, bind
to and exhibit cyclin–CDK complexes. The crystal structure
of the human p27Kip1 kinase inhibitory domain bound to the
phosphorlyated cyclin A–cyclin-dependent kinase 2 (Cdk2)
complex has been determined at 2.3 Å. p27Kip1 binds the
complex as an extended structure interacting with both cyclin
A and Cdk2. On cyclin A, it binds in a groove formed by
conserved cyclin box residues. On Cdk2, it binds and
rearranges the amino-terminal lobe and also inserts into the
catalytic cleft, mimicking ATP. These observations provide a
molecular basis for kinase inhibition.
25 July 1996, Nature
n Cryo-electron microscopy studies of empty capsids of
human parvovirus B19 complexed with its cellular
receptor. Paul R Chipman, Mavis Agbandje-McKenna,
Sachiko Kajigaya, Kevin E Brown, Neal S Young, Timothy S
Baker and Michael G Rossmann (1996). Proc. Natl. Acad.
Sci. USA 93, 7502–7506.
The three-dimensional structures of human parvovirus B19
VP2 capsids, alone and complexed with its cellular receptor,
globoside, are described at 26 Å resolution. The B19 capsid
structure has depressions on the icosahedral twofold  and
threefold axes, as well as a canyon-like region around the
fivefold axes. Similar results had previously been found in an 8
Å resolution map derived from X-ray diffraction data. The
glycolipid receptor molecules bind into the depressions on the
threefold axes of the B19–globoside complex. A model of the
tetrasaccharide component of globoside, organized as a trimeric
fiber, fits well into the difference density representing the
globoside receptor. The proximity of antigenic epitopes to the
receptor site suggests that neutralization of virus infectivity is
caused by preventing attachment of viruses to cells.
23 July 1996, Proceedings of the National Academy of
Sciences of the USA
n Structure of the catalytic fragment of poly(ADP-ribose)
polymerase from chicken. Armin Ruf, Josiane Ménissier
de Murcia, Gilbert M de Murcia and Georg E Schulz
(1996). Proc. Natl. Acad. Sci. USA 93, 7481–7485.
The crystal structures of the catalytic fragment of chicken
poly(ADP-ribose) polymerase with and without a
nicotinamide-analogue inhibitor are described. Because this
enzyme is involved in the regulation of DNA repair, its
inhibitors are of interest for cancer therapy. The inhibitor
shows the nicotinamide site and also suggests the adenosine
site. The enzyme is structurally related to bacterial ADP-
ribosylating toxins but contains an additional a-helical domain
that is suggested to relay the activation signal issued on
binding to damaged DNA.
23 July 1996, Proceedings of the National Academy of
Sciences of the USA
n Structure of the amino-terminal core domain of the
HIV-1 capsid protein. Rossitza K Gitti, Brian M Lee, Jill
Walker, Michael F Summers, Sanghee Yoo and Wesley I
Sundquist (1996). Science 273, 231–235.
This paper describes the solution structure of the amino-
terminal core domain (residues 1–151) of the human
immunodeficiency virus-type 1 (HIV-1) capsid protein. The
structure is unlike those of previously characterized viral coat
proteins and is composed of seven a helices, two b hairpins,
and an exposed partially ordered loop. The domain is shaped
like an arrowhead, with the b hairpins and loop exposed at the
trailing edge and the carboxyl-terminal helix projecting from
the tip. The proline residue Pro1 forms a salt bridge with a
conserved, buried aspartate residue (Asp51), which suggests
that the amino terminus of the protein rearranges upon
proteolytic maturation. The binding site for cyclophilin A, a
cellular rotamase that is packaged into the HIV-1 virion, is
located on the exposed loop and encompasses the essential
proline residue Pro90. In the free monomeric domain, Pro90
adopts kinetically trapped cis and trans conformations, raising
the possibility that cyclophilin A catalyzes interconversion of
the cis- and trans-Pro90 loop structures.
12 July 1996, Science
n Structure of the FKBP12-Rapamycin complex
interacting with the binding domain of human FRAP.
Jungwon Choi, Jie Chen, Stuart L Schreiber, Jon Clardy
(1996). Science 273, 239–241.
Rapamycin, a potent immunosuppressive agent, binds two
proteins: the FK506-binding protein (FKBP12) and the FKBP-
rapamycin-associated protein (FRAP). The crystal structure of
the ternary complex of human FKBP12, rapamycin, and the
FKBP12-rapamycin-binding (FRB) domain of human FRAP at
a resolution of 2.7 Å shows that rapamycin occupies two
different hydrophobic-binding pockets simultaneously. There
are extensive interactions between rapamycin and both
proteins explaining how rapamycin induces protein
dimerization.
12 July 1996, Science
n Functional mimicry of a protein hormone by a peptide
agonist: the EPO receptor complex at 2.8 Å. Oded
Livnah, Enrico A Stura, Dana L Johnson, Steven A
Middleton, Linda S Mulcahy, Nicholas C Wrighton, William
J Dower, Linda K Jolliffe and Ian A Wilson (1996). Science
273, 464–471.
The biological activity of a 166-residue hematopoietic growth
hormone, erythropoietin (EPO), with its class 1 cytokine
receptor has been mimicked by a 20-residue cyclic peptide
unrelated in sequence to the natural ligand. The crystal
structure at 2.8 Å resolution of a complex of this agonist
peptide with the extracellular domain of EPO receptor reveals
that a peptide dimer induces an almost perfect twofold
dimerization of the receptor. The dimer assembly differs from
that of the human growth hormone (hGH) receptor complex.
The EPO receptor-binding site, defined by peptide
interaction, corresponds to the smaller functional epitope
identified for hGH receptor. These data suggest that the
design of nonpeptidic small molecule mimetics for EPO and
other cytokines may be achievable.
26 July 1996, Science
n The three-dimensional structure of apopain/CPP32, a
key mediator of apoptosis. Jennifer Rotonda, Donald W
Nicholson, Kimberly M Fazil, Michel Gallant, Yves Gareau,
Marc Labelle, Erin P Peterson, Dita M Rasper, Rejean Ruel,
John P Vaillancourt, Nancy A Thornberry and Joseph W
Becker (1996). Nat. Struct. Biol. 3, 619–625.
Cysteine proteases related to mammalian interleukin-1b
converting enzyme (ICE) and to its Caenorhabditis elegans
homologue, CED-3, play a critical role in the biochemical
events that culminate in apoptosis. This paper describes the
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crystal structure of a complex of the human CED-3 homologue
CPP32/apopain with a tetrapeptide-aldehyde inhibitor. The
protein resembles ICE in overall structure, but its S4 subsite is
different in size and chemical composition. These differences
account for the variation in specificity between the ICE- and
CED-3-related proteases and should assist in drug design.
7 July 1996, Nature Structural Biology
n The solution structure of the bovine leukaemia virus
matrix protein and similarity with lentiviral matrix
proteins. Stephen Matthews, Michael Mikhailov, Arsene
Burny and Polly Roy (1996). EMBO J. 15, 3267–3274.
In the mature virion, retroviral matrix proteins are found in
association with the inner face of the viral membrane. They
play a critical role in determining the morphogenesis of virus
assembly. This paper describes the solution structure of the
bovine leukaemia virus (BLV) matrix protein. The protein
contains four principal helices joined by short loops. Despite
no sequence similarity the structure shows homology with the
equivalent protein from the human and simian
immunodeficiency viruses. The similarity implies a possible
common assembly unit for the matrix proteins of type C
retroviruses.
1 July 1996, The EMBO Journal
n Nuclear magnetic resonance solution structure of the
human Hsp40 (HDJ-1) J-domain. Yan Qiu Qian, Dinshaw
Patel, F-Ulrich Hartl and Damian J McColl (1996). J. Mol.
Biol. 260, 224–235.
The J-domain is a highly conserved domain found in all
members of the DnaJ family of molecular chaperones. The
solution structure of the 77-residue polypeptide from Hsp40
includes four helices. The first three helices form a closed
structural core; the less defined helix IV stands away from the
core of the domain. The side-chains of the tripeptide His-Pro-
Asp extend out from the core of the structure in the opposite
direction from helix IV supporting the hypothesis that the
tripeptide is involved in the interaction of Hsp40 with the
molecular chaperone, Hsp70. A second recent paper describes
the NMR structure of the related homologous domain from
Escherichia coli DnaJ. While the overall structure and
conclusions are similar, the orientation of helix IV differs.
leading to changes in the hydrophobic core (see Pellecchia, M.,
Szyperski, T., Wall, D., Georgopoulos, C. & Wuthrich, K.J.
Mol. Biol. 260, 236–250).
12 July 1996, Journal of Molecular Biology
n Structure of the CAP–DNA complex at 2.5 Å resolution:
a complete picture of the protein–DNA interface. Gary
Parkinson, Christopher Wilson, Angelo Gunasekera, Yon
W Ebright, Richard E Ebright and Helen M Berman (1996).
J. Mol. Biol. 260, 395–408.
The Escherichia coli catabolite gene activator protein (CAP) is
involved in transcriptional activation. The crystal structure of
the CAP–DNA complex at 3.0 Å resolution has been reported
previously. The reported structure was determined using a
gapped DNA molecule lacking two phosphates important for
CAP–DNA interaction. In this paper, the authors report the
crystallographic structure of the CAP–DNA complex at 2.5 Å
resolution using a DNA molecule having all phosphates
important for CAP–DNA interaction. The new data permits
unambiguous identification of protein–DNA contacts and the
accurate definition of the kinked DNA conformation in the
CAP–DNA complex.
19 July 1996, Journal of Molecular Biology
n The 1.6 Å resolution crystal structure of nuclear
transport factor 2 (NTF2). Timothy L Bullock, W David
Clarkson, Helen M Kent and Murray Stewart (1996). J.
Mol. Biol. 260, 422–431.
Nuclear transport factor 2 (NTF2) facilitates protein transport
into the nucleus and interacts with both the small Ras-like
GTPase Ran and nucleoporin p62. The authors have
determined the structure of bacterially expressed rat NTF2 at
1.6 Å resolution. The NTF2 polypeptide chain forms an a + b
barrel that opens at one end to form a distinctive hydrophobic
cavity. Its fold is homologous to that of scytalone dehydratase.
The NTF2 hydrophobic cavity is a candidate binding site for
other proteins involved in nuclear import such as Ran and
nucleoporin p62. In addition, the hydrophobic cavity contains a
putative catalytic Asp-His pair, although no catalytic activity
has been reported.
19 July 1996, Journal of Molecular Biology
n Three-dimensional solution structure and 13C nuclear
magnetic resonance assignments of the colicin E9
immunity protein Im9. Michael J Osborne, Alexander L
Breeze, Lu-Yun Lian, Ann Reilly, Richard James,Colin
Kleanthous and Geoffrey R Moore (1996). Biochemistry
35, 9505–9512.
Colicin E9 (Col E9) is a plasmid-encoded DNase that is
secreted as part of the stress response system of some
Escherichia coli. This paper describes the solution structure of
the 86-amino acid Col E9 immunity protein (Im9), which
inhibits the DNase activity of Col E9. The Im9 fold is a
distorted antiparallel four-helix bundle, in which the third
helix is rather short. The structure is consistent with
biochemical data on the interaction between Im9 and its
target DNase. Important residues of Im9 that govern
specificity are located on the molecular surface in a region rich
in negatively charged groups, consistent with the proposed
electrostatically steered association.
23 July 1996, Biochemistry
n Crystal structure of the wide-spectrum binuclear zinc
b-lactamase from Bacteroides fragilis. Nestor O
Concha, Beth A Rasmussen, Karen Bush and Osnat
Herzberg. Structure 4, 823–836.
The metallo-b-lactamase from Bacteroides fragilis hydrolyzes a
wide range of b-lactam antibiotics, and is not clinically
susceptible to any known  b-lactamase inhibitors. The crystal
structure of the enzyme has been determined by using
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multiwavelength anomalous diffraction at the zinc absorption
edge. The structure is a four-layer a/b/b/a molecule. The
active site, found at the edge of the b sandwich, contains a
binuclear zinc center with several novel features. One zinc is
tetrahedrally coordinated, the other has a trigonal bipyramidal
coordination; a water/hydroxide molecule serves as a ligand for
both metals.  Structural analysis indicates that affinity for the
penta-coordinated zinc can be modulated by neighboring
residues, perhaps explaining why, despite the existence of a
pattern for binuclear zinc binding, the reported structure of
the related Bacillus cereus enzyme contains only a single zinc.
15 July 1996, Structure
n Insights into specificity of cleavage and mechanism of
cell entry from the crystal structure of the highly
specific Aspergillus ribotoxin, restrictocin. Xiaojing Yang
and Keith Moffat (1996) Structure 4, 837–852.
Restrictocin, a highly specific ribotoxin made by the fungus
Aspergillus restrictus, cleaves a single phosphodiester bond in
the 28S RNA of eukaryotic ribosomes, inhibiting protein
synthesis. The crystal structure of restrictocin was deter-
mined at 1.7 Å resolution. The structural core of the protein,
in which a three-turn a helix is packed against a five-stranded
antiparallel b sheet, can be well aligned with that of
ribonuclease T1. Large positively charged peripheral loops
near the active site construct a platform with a concave
surface for RNA binding. Restrictocin appears to combine the
catalytic components of T1 ribonucleases with the base
recognition components of Sa ribonucleases. A large 39-
residue loop may be responsible for restrictocin’s ability to
cross cell membranes.
15 July 1996, Structure
n The first step in sugar transport: crystal structure of the
amino terminal domain of enzyme I of the E. coli PEP:
sugar phosphotransferase system and a model of the
phosphotransfer complex with HPr. D-I Liao, E Silverton,
Y-J Seok, BR Lee, A Peterkofsky and DR Davies (1996).
Structure 4, 861–872.
The bacterial phosphoenolpyruvate (PEP): sugar phospho-
transferase system (PTS) transports exogenous hexose sugars
through the membrane and tightly couples transport with
phosphoryl transfer from PEP to the sugar via several
phosphoprotein intermediates. The phosphate group is first
transferred to enzyme I, second to the histidine-containing
phosphocarrier protein HPr, and then to one of a number of
sugar-specific enzymes II. The structures of several HPrs and
enzymes IIA are known. The structure of the N-terminal half
of enzyme I from Escherichia coli (EIN) is described here at
2.5 Å resolution. It has two distinct structural subdomains:
one contains four a helices arranged as two hairpins, the other
is a b sandwich together with three short a helices. Plausible
models of complexes between EIN and HPr can be made
without assuming major structural changes in either protein.
15 July 1996, Structure
n Structural basis for the excision repair of alkylation-
damaged DNA. Jörg Labahn, Orlando D Scharer,
Alexander Long, Khosro Ezaz-Nikpay, Gregory L Verdine
and Tom E Ellenberger (1996). Cell 86, 321–329.
Base-excision DNA repair proteins that target alkylation
damage act on a variety of seemingly dissimilar adducts, yet
fail to recognize other closely related lesions. The 1.8 Å crystal
structure of the monofunctional DNA glycosylase AlkA (E. coli
3-methyladenine-DNA glycosylase II) reveals a large
hydrophobic cleft unusually rich in aromatic residues. An
aspartic acid residue projecting into this cleft is essential for
catalysis. AlkA is similar in fold and active site location to the
bifunctional glycosylase/lyase endonuclease III, suggesting
that the two may employ related mechanisms for base excision.
(A similar structure is reported by Yamagata, Y., et al., & Fujii,
S. Cell 86, 311–319.)
26 July 1996, Cell
n Bacterial chitobiase structure provides insight into
catalytic mechanism and the basis of Tay-Sachs
disease. Ivo Tews, Anastassis Perrakis, Amos Oppenheim,
Zbigniew Dauter, Keith S Wilson and Constantin E Vorgias
(1996). Nat. Struct. Biol. 3, 638–648.
Chitin, the second most abundant polysaccharide on earth, is
degraded by chitinases and chitobiases. Serratia marcescens is a
member of a family that also contains other chitobiase
enzymes, the hexosaminidases, which hydrolyse GM2-type
gangliosides in higher organisms. The structure of Serratia
marcescens chitobiase has been refined at 1.9 Å resolution. The
mature protein is folded into four domains and its active site is
situated at the C-terminal end of the central (ba)8-barrel.
Based on the structure of the complex with the substrate
disaccharide chitobiose, the authors propose an acid-base
reaction mechanism. The structure allows one to model the
catalytic domain of the homologous hexosaminidases to give a
structural rationale to pathogenic mutations that lead to the
accumulation of gangliosides and underlie Tay-Sachs and
Sandhoff disease.
7 July 1996, Nature Structural Biology
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